Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Jack

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Blood|July 28, 2009
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphomaDavid Dornan, Fiona Bennett, Yvonne Chen, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
The Oncologist|August 14, 2015
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)Amie E Jackson, Michael Mian, Christina Kalpadakis, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab MonotherapyEmanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 13, 2024
Canadian Spine Society: 24th Annual Scientific Conference, Wednesday, February 28 - Saturday, March 2, Fairmont Chateau Whistler, Whistler, B.C., CanadaAntoine Dionne, Majeed Al-Zakri, Hubert Labelle, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Blood|July 28, 2009
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphomaDavid Dornan, Fiona Bennett, Yvonne Chen, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
The Oncologist|August 14, 2015
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)Amie E Jackson, Michael Mian, Christina Kalpadakis, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab MonotherapyEmanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 13, 2024
Canadian Spine Society: 24th Annual Scientific Conference, Wednesday, February 28 - Saturday, March 2, Fairmont Chateau Whistler, Whistler, B.C., CanadaAntoine Dionne, Majeed Al-Zakri, Hubert Labelle, et al.
Pageof 10